Published Date: 02 Mar 2023
A new study by Prof. Boaz Ben-David and Rony Lemel of Reichman University's Baruch Ivcher School of Psychology has found that attention deficit hyperactivity disorder (ADHD) causes slow and difficult understanding of words.
Read Full NewsSanofi's tolebrutinib fails to meet key trial endpoints for multiple sclerosis, delaying FDA review and raising questions about its future in treatment.
Neal K. Shah talked about how social robots could support emotional well-being in patients with neurologic conditions by reducing loneliness and promoting engagement in health-related activities.
Christopher Kenney, MD, FAAN, chief medical officer at Xenon Pharmaceuticals, reviews encouraging long-term data behind azetukalner, a first-in-class Kv7 channel opener, as a potential treatment for focal onset seizures.
This video explores skin pain as a key symptom of atopic dermatitis and reviews clinical trial data with JAK inhibitors.
Chronic Pain Associated With Significantly Reduced Ability to Relax Muscles
Global Data Suggest Increased Prevalence of Focal Segmental Glomerulosclerosis
Older Patients on Maintenance Dialysis Underrepresented in RCTs
1.
Virtual Reality Travel Reduces Cancer Pain.
2.
Why palliative care goes hand in hand with treatment for people with cancer: Q&A
3.
Alcohol Causes Cancer. We Should Be Drinking Less.
4.
Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.
5.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
1.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
2.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
3.
HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review
4.
Beyond Symptoms: The Predictive Promise of Targeted Radionuclide Therapy in Palliative Oncology
5.
Unveiling the Mystery of Castleman's Disease: A Journey to Better Health
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Navigating the Complexities of Ph Negative ALL - Part VII
5.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation